Bayer Schering Pharma to expand contraceptive market share

Bayer Schering Pharma is gearing up to expand its presence in the domestic contraceptive market by launching a new low-dose oral contraceptive called Yasmin in October, together with Postinor-1, an emergent oral contraceptive pill.

This pill - the best-selling contraceptive worldwide - contains 30 mcg of ethinyl estradiol ("low dose") along with a unique progestin that also helps reduce wat...